Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Knudsen

Showing results (341-350 of 466) with videos related to

Pageof 47
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2010
Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effectMichael C Risk, Beatrice S Knudsen, Ilsa Coleman, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Optimization and Evaluation of Al<sup>18</sup>F Labeling Using a NOTA-or RESCA1-Conjugated AE105 Peptide Antagonist of uPARTroels E Jeppesen, Marina Simón, Josephine Torp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosisDaniel W Lin, Ilsa M Coleman, Sarah Hawley, et al.
Plos One|April 7, 2021
The pulmonary mycobiome-A study of subjects with and without chronic obstructive pulmonary diseaseEinar M H Martinsen, Tomas M L Eagan, Elise O Leiten, et al.
Molecular Carcinogenesis|October 23, 2008
Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b)Paola Rojas, Fernando Benavides, Jorge Blando, et al.
Cell Reports|December 16, 2014
MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependenciesGuemHee Baek, Yan F Tse, Zeping Hu, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 28, 2010
Activation of the MEK-S6 pathway in high-grade ovarian cancersAviva P Ventura, Sabarinath Radhakrishnan, Ann Green, et al.
Cell Cycle (Georgetown, Tex.)|July 4, 2012
CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapyA Kathleen McClendon, Jeffry L Dean, Dayana B Rivadeneira, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 12, 2023
Screening for pre-eclampsia with competing-risks model using placental growth factor measurement in blood samples collected before 11 weeks' gestationI Riishede, C K Ekelund, L Sperling, et al.
The Journal of Biological Chemistry|January 8, 2011
Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor functionClay E S Comstock, Michael A Augello, Matthew J Schiewer, et al.
Pageof 47

Showing results (341-350 of 466) with videos related to

Sort By:
Pageof 47
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2010
Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effectMichael C Risk, Beatrice S Knudsen, Ilsa Coleman, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Optimization and Evaluation of Al<sup>18</sup>F Labeling Using a NOTA-or RESCA1-Conjugated AE105 Peptide Antagonist of uPARTroels E Jeppesen, Marina Simón, Josephine Torp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2006
Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosisDaniel W Lin, Ilsa M Coleman, Sarah Hawley, et al.
Plos One|April 7, 2021
The pulmonary mycobiome-A study of subjects with and without chronic obstructive pulmonary diseaseEinar M H Martinsen, Tomas M L Eagan, Elise O Leiten, et al.
Molecular Carcinogenesis|October 23, 2008
Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b)Paola Rojas, Fernando Benavides, Jorge Blando, et al.
Cell Reports|December 16, 2014
MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependenciesGuemHee Baek, Yan F Tse, Zeping Hu, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|July 28, 2010
Activation of the MEK-S6 pathway in high-grade ovarian cancersAviva P Ventura, Sabarinath Radhakrishnan, Ann Green, et al.
Cell Cycle (Georgetown, Tex.)|July 4, 2012
CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapyA Kathleen McClendon, Jeffry L Dean, Dayana B Rivadeneira, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 12, 2023
Screening for pre-eclampsia with competing-risks model using placental growth factor measurement in blood samples collected before 11 weeks' gestationI Riishede, C K Ekelund, L Sperling, et al.
The Journal of Biological Chemistry|January 8, 2011
Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor functionClay E S Comstock, Michael A Augello, Matthew J Schiewer, et al.
Pageof 47